Form 8-K · Current report
Linde plc 8-K, filed Jul 30, 2026
- Filed
- CIK
- 0001707925
- Accession no.
- 0001193125-26-325127
Summary
At Linde plc's annual general meeting on July 28, 2026, shareholders elected nine director nominees, ratified PricewaterhouseCoopers as independent auditor, approved auditor remuneration and named executive officer compensation, and approved a treasury share re-allotment price range; they rejected a shareholder proposal requesting a report on renewable electricity procurement.
Key points
- Shareholders holding 396,007,872 shares, or 85.65% of shares outstanding and entitled to vote, were present or represented by proxy, constituting a quorum.
- All nine director nominees were elected, with support ranging from 93.55% to 99.42% of votes cast.
- Shareholders ratified PricewaterhouseCoopers as independent auditor and approved the board's authority to determine its remuneration.
- A shareholder proposal requesting a report on Linde's renewable electricity procurement strategy was rejected, with 82% of votes cast against.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.07Submission of Matters to a Vote of Security Holders
- 9.01Financial Statements and Exhibits
From the filing
ITEM 5.07 Submission of Matters to a Vote of Security Holders The Linde plc Annual General Meeting of Shareholders was held on July 28, 2026 (the “AGM”), at which shareholders voted upon the items set forth below. The total number of shares that were present or represented by proxy at the Annual Meeting was 396,007,872 which was 85.65% of the shares outstanding and entitled to vote and which constituted a quorum. The final voting results of the items submitted to a vote of the shareholders are set forth below. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.